UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013288
Receipt No. R000015214
Scientific Title A Multi-Center Seamless Phase II-III Randomized Trial of High-dose Cytarabine in Initial Induction with Evaluation of Flow-cytometry-based Minimal Residual Disease for Children with de Novo Acute Myeloid Leukemia (AML-12)
Date of disclosure of the study information 2014/03/01
Last modified on 2018/03/16 21:03:25

No. Disposal Last modified on Item of update
1 Insert 2014/02/26 18:52:50
2 Update 2014/04/22 12:20:37 Recruitment status
3 Update 2014/04/22 12:26:53 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
TEL
4 Update 2014/09/13 00:01:37 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
5 Update 2018/03/16 20:59:52 Recruitment status
6 Update 2018/03/16 21:03:25 Name of primary sponsor
Organization
Category of Funding Organization


Contact us.